Latest Breaking News On - Factor bioscience inc - Page 1 : vimarsana.com

Factor Bioscience Successfully Defends Three U S Patents Covering Foundational Methods for Therapeutic Gene Editing

Factor Bioscience Successfully Defends Three U S Patents Covering Foundational Methods for Therapeutic Gene Editing
tmcnet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tmcnet.com Daily Mail and Mail on Sunday newspapers.

United statesUnited kingdomChristopher rohdeWilson sonsini goodrich rosatiMatt angelTechnology officerTrademark officeFactor bioscience incCovering foundational methodsTherapeutic geneUnited states patentChief technologyWilson sonsini goodrich

Factor Bioscience Successfully Defends Three U S Patents Covering Foundational Methods For Therapeutic Gene Editing

-Patented methods relate to multiple allogeneic CAR T-cell therapies under clinical development for the treatment of B-cell lymphoma, chronic lympho

United statesUnited kingdomChristopher rohdeWilson sonsini goodrich rosatiMatt angelTrademark officeFactor bioscience incTechnology officerBioscience incUnited states patentChief technologyWilson sonsini goodrich

Lineage Announces Initiation of Development Activities for Hypoimmune Pluripotent Cell Line for Neurology Indications Under Partnership With Eterna Therapeutics

Lineage Cell Therapeutics, Inc. ; class= js-l-obf link link blue

United statesMatt angelBrianm culleyRoche groupEterna therapeutics incFactor bioscience incExchange commissionLineage cell therapeutics incLineage cell therapeuticsEterna therapeuticsChief executive officerCell therapeuticsFactor bioscienceAnnual reportQuarterly report

Eterna Therapeutics Appoints Matt Angel, Ph D as Chief Executive Officer and President

Eterna Therapeutics Appoints Matt Angel, Ph D as Chief Executive Officer and President
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United kingdomMatt angelCharles cheringtonEterna therapeuticseternaExacis biotherapeuticsCompany board of directorsMassachusetts institute of technologyPrinceton universityFactor bioscience incExchange commissionEterna therapeutics incSecurities exchangeChief executive officerScientific advisory board chairChief scientific officerNovellus therapeutics

In a New Audio Interview, Toni Loudenbeck of Traders News Source Interviews Dr Matt Angel, CEO Eterna Therapeutics

NEW YORK, NY / ACCESSWIRE / December 20, 2022 / Traders News Source, a leading independent equity research and corporate access firm focused on small and mid-cap publicly traded companies recently issued

Matt angelToni loudenbeckExacis biotherapeuticsMark robertsMassachusetts institute of technologyFactor bioscience incTraders news sourceEterna therapeuticsNews sourceFactor bioscienceNovellus therapeuticsMassachusetts instituteNews source editor toni loudenbeckRelations contact